Intelligent Bio Solutions PE Ratio 2020-2024 | INBS
Current and historical p/e ratio for Intelligent Bio Solutions (INBS) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Intelligent Bio Solutions PE ratio as of November 22, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Intelligent Bio Solutions PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-11-21 | 1.64 | 0.00 | |
2024-09-30 | 1.73 | $-4.20 | 0.00 |
2024-06-30 | 1.92 | $-15.99 | 0.00 |
2024-03-31 | 4.22 | $-38.91 | 0.00 |
2023-12-31 | 0.34 | $-106.15 | 0.00 |
2023-09-30 | 1.03 | $-109.60 | 0.00 |
2023-06-30 | 2.78 | $-97.12 | 0.00 |
2023-03-31 | 2.90 | $-107.80 | 0.00 |
2022-12-31 | 0.20 | $-60.74 | 0.00 |
2022-09-30 | 0.42 | $-110.44 | 0.00 |
2022-06-30 | 0.66 | $-110.44 | 0.00 |
2022-03-31 | 0.78 | $-141.66 | 0.00 |
2021-12-31 | 1.44 | $-175.27 | 0.00 |
2021-06-30 | 3.94 | $-144.06 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.007B | $0.003B |
Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.361B | 11.58 |
Cencora (COR) | United States | $48.280B | 17.81 |
DiDi Global (DIDIY) | China | $22.212B | 0.00 |
Natera (NTRA) | United States | $22.082B | 0.00 |
ICON (ICLR) | Ireland | $17.675B | 15.74 |
Viatris (VTRS) | United States | $15.958B | 4.92 |
Avantor (AVTR) | United States | $14.143B | 21.20 |
Revvity (RVTY) | United States | $13.634B | 23.68 |
CochLear (CHEOY) | Australia | $12.777B | 0.00 |
Solventum (SOLV) | United States | $12.233B | 0.00 |
BioMerieux (BMXMF) | France | $11.895B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
HealthEquity (HQY) | United States | $9.104B | 49.41 |
Doximity (DOCS) | United States | $8.999B | 52.97 |
Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
Life Times (LTH) | United States | $5.081B | 33.63 |
Organon (OGN) | United States | $3.935B | 3.97 |
Sotera Health (SHC) | United States | $3.631B | 19.42 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
Concentras Parent (CON) | United States | $2.789B | 0.00 |
PACS (PACS) | United States | $2.515B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
Premier (PINC) | United States | $2.195B | 11.42 |
GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
Progyny (PGNY) | United States | $1.315B | 26.62 |
Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
CareDx (CDNA) | United States | $1.241B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
Embecta (EMBC) | United States | $0.797B | 5.32 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.779B | 0.00 |
SBC Medicals (SBC) | United States | $0.674B | 0.00 |
InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
DocGo (DCGO) | United States | $0.434B | 16.35 |
Enhabit (EHAB) | United States | $0.380B | 32.87 |
COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
ModivCare (MODV) | United States | $0.254B | 13.79 |
LifeMD (LFMD) | United States | $0.251B | 0.00 |
Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
Biodesix (BDSX) | United States | $0.186B | 0.00 |
Nutex Health (NUTX) | United States | $0.179B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
MultiPlan (MPLN) | United States | $0.112B | 0.00 |
So-Young (SY) | China | $0.086B | 16.60 |
Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.10 |
IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |